Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-21
DOI
10.3389/fphar.2020.01117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis: The Future of Quantitative Analysis
- (2018) Xiaoping Wu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)
- (2018) Thida Win et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Optimising experimental research in respiratory diseases: an ERS statement
- (2018) Philippe Bonniaud et al. EUROPEAN RESPIRATORY JOURNAL
- Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice
- (2018) Richard D. Bell et al. PLoS One
- Use of animal models in IPF research
- (2018) R. Carrington et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
- (2018) Francesca Ruscitti et al. Jove-Journal of Visualized Experiments
- Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
- (2018) David A Lynch et al. Lancet Respiratory Medicine
- Lung transplantation in idiopathic pulmonary fibrosis
- (2018) Anupam Kumar et al. Expert Review of Respiratory Medicine
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors
- (2018) Adam C. Calaway et al. JOURNAL OF CLINICAL ONCOLOGY
- Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study
- (2018) Simon L F Walsh et al. Lancet Respiratory Medicine
- Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF
- (2018) Nicholas D Weatherley et al. THORAX
- Investigational drugs for idiopathic pulmonary fibrosis
- (2017) Francesco Varone et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist
- (2017) Nicola Sverzellati et al. Radiologia Medica
- Type I collagen–targeted PET probe for pulmonary fibrosis detection and staging in preclinical models
- (2017) Pauline Désogère et al. Science Translational Medicine
- Imaging pathophysiological changes in the lungs in IPF with xenon magnetic resonance imaging
- (2017) Jim M Wild THORAX
- Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice
- (2017) Francesca Ruscitti et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
- (2017) Gabriella Bergamini et al. Jove-Journal of Visualized Experiments
- Heterologous Matrix Metalloproteinase Gene Promoter Activity Allows In Vivo Real-time Imaging of Bleomycin-Induced Lung Fibrosis in Transiently Transgenized Mice
- (2017) Fabio Franco Stellari et al. Frontiers in Immunology
- Idiopathic pulmonary fibrosis
- (2017) Fernando J. Martinez et al. Nature Reviews Disease Primers
- Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes
- (2016) Nimali P. Withana et al. Scientific Reports
- Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume
- (2015) Greetje Vande Velde et al. Disease Models & Mechanisms
- Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model
- (2015) Fabio Stellari et al. Journal of Translational Medicine
- In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin
- (2015) Fabio Stellari et al. Journal of Translational Medicine
- Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230
- (2014) Christine Egger et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Administration of Bleomycin via the Oropharyngeal Aspiration Route Leads to Sustained Lung Fibrosis in Mice and Rats as Quantified by UTE-MRI and Histology
- (2013) Christine Egger et al. PLoS One
- In Vivo Imaging of Transiently Transgenized Mice with a Bovine Interleukin 8 (CXCL8) Promoter/Luciferase Reporter Construct
- (2012) Fabio Franco Stellari et al. PLoS One
- Bleomycin revisited: towards a more representative model of IPF?
- (2010) Chris J. Scotton et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Oropharyngeal aspiration: An alternative route for challenging in a mouse model of chemical-induced asthma
- (2009) Vanessa De Vooght et al. TOXICOLOGY
- Standardized quantification of pulmonary fibrosis in histological samples
- (2008) Ralf-Harto Hübner et al. BIOTECHNIQUES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started